Navigation Links
Genmab Announces Year End 2007 Financial Results
Date:3/31/2008

Genmab Reports Financial Results for the 12 Months Ended December 31, 2007

COPENHAGEN, Denmark, March 31 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today results for the financial year ended December 31, 2007.

Revenues of DKK 530 million (approximately USD 104 million) compared to DKK 136 million (approximately USD 27 million) in 2006.

An Operating Loss of DKK 437 million (approximately USD 86 million). This compares to an Operating Loss of DKK 472 million (approximately USD 93 million) reported in 2006.

Net Financial Income totaled DKK 54 million (approximately USD 11 million) compared to Net Financial Income of DKK 34 million (approximately USD 7 million) in 2006.

A Net Loss of DKK 383 million (approximately USD 76 million) compared to a Net Loss in 2006 of DKK 438 million (approximately USD 86 million). The Net Loss per share was DKK 8.72 (approximately USD 1.72) in 2007 compared to a Net Loss per share of DKK 11.26 (approximately USD 2.22) in 2006. The 2007 Net Loss exceeded Genmab's guidance of DKK 260 to 310 million as a development milestone payment projected for late 2007 was not received until January 2008. The milestone payment of DKK 87 million was triggered by the first patient receiving treatment in the HuMax-CD20 (ofatumumab) Phase III rheumatoid arthritis (RA) program.

Genmab ended the year with a cash position of DKK 3.7 billion (approximately USD 728 million), which is an increase of approximately DKK 2.0 billion (approximately USD 388 million) from the end of 2006.

USD 1.00 = DKK 5.075 (Danish Central Bank's spot rate on December 31, 2007)

2007 Highlights:

Genmab achieved a number of business and scientific milestones, as follows:

Partnership progress:

Genmab and GlaxoSmithKline received antitrust clearance for the

HuMax-CD20 co-development and commercialization agreement; achieved first

two milestones in collaboration

Achieved
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Genmab Announces 2007 First Half Year Results
2. Genmab Announces Encouraging Preclinical Data for ofatumumab
3. Genmab Discloses Target and Development Plans for HuMax-Inflam
4. Genmab Announces Asset Exchange Agreement
5. Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study
6. Genmab A/S - Company Announcement
7. Genmab Amends HuMax-CD4 Pivotal Study in CTCL
8. Phase I Results Announced for R1507 From Genmabs Collaboration With Roche
9. Genmab Announces Results for the First Nine Months of 2007
10. Genmab Announces Update on Recruitment of Patients in ofatumumab CLL Pivotal Study
11. Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... (NYSE: MOS ) plans to issue its ... tables on Tuesday, January 5, 2010, after the close ... Results will be available on Mosaic,s website at mosaicco.com/investors. ... call with presentation slides on Wednesday, January 6, 2010, ... at 11:00 a.m. Eastern Standard Time (10:00 a.m. Central ...
(Date:12/15/2009)... Center for Business Intelligence (CBI), a division ... the full agenda for the 6th ... The forum will take place at the ... Over 1,500 senior-level Finance, Accounting, Audit and ... since its inception, and this year,s meeting ...
(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...
(Date:12/15/2009)... Office has announced the launch of several innovative new ... services in the current economic climate. The first ... to finance legal services over a period of 6, ... in their start-up companies. The second is aimed ... payment arrangements over 6 to 12 month period at ...
Breaking Biology Technology:Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2
... ADHD ages 6 to 65, RARITAN, N.J., June ... behavioral disorder treated in children(1), and,according to the National ... percent of children with ADHD continue to exhibit symptoms,in ... eight million, or,one in 20, adults in the United ...
... VIAP ), a biotechnology company focused on the ... join the,Russell Microcap Index when Russell Investments reconstitutes its ... according to a preliminary list,of additions posted on ... selected for inclusion in this objective,market-driven index as we ...
... The Spanish flu outbreak of 1918 killed between 30 ... ultimate cause of death was acute respiratory distress syndrome ... the body during which the lung becomes severely damaged. ... infections, but also by chemical agents. These could be ...
Other Biology Technology:FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults 2FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults 3FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults 4VIA Pharmaceuticals Set to Join Russell Microcap Index 2VIA Pharmaceuticals Set to Join Russell Microcap Index 3VIA Pharmaceuticals Set to Join Russell Microcap Index 4New strategies against bird flu 2
(Date:12/16/2009)... DigitalPersona, Inc., a leader in ... an agreement with IBM to deploy a ... technology on IBM SurePOS 500 retail systems. ... applications to more easily and quickly identify ... linked to the individuals who perform them. ...
(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin ... safety and finger-based biometric identification solutions, announced ... a Special Shareholder Meeting held today approved ... Division to Interact911 Mobile Systems Inc. Of ... favor and 1.2% were opposed. ,, (Logo: ...
(Date:12/16/2009)... Texas, Dec. 8, 2009 National ... in industrial measurement and control, and DENSO ... automation using robotics technology, today announced their ... technology with DENSO robotic arms. The collaboration ... research and flexible manufacturing applications. In today,s ...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5Free Braces Screening Exam Day June 19 49421 1Free Braces Screening Exam Day June 19 49421 2Swine Flu Outbreak at Miami Immigration Center to be Discussed on AFGE Radio Show 49418 1Swine Flu Outbreak at Miami Immigration Center to be Discussed on AFGE Radio Show 49418 2Work Stress for Mom Might Harm Baby 49415 1
... Hopkins have figured out how one particular protein contributes to ... an hour or two. The findings are reported in two ... protein, called Arc, has been implicated in memory-linked behaviors ranging ... 3-D space. In people, Arc may be one culprit behind ...
... first time, scientists have engineered yeast cells capable ... proteins with fully human sugar structures (glycosylation). These ... half-life and to date, have necessitated the expression ... reported today has the potential to eliminate the ...
... life's first cells, Irene Chen, a regional winner from ... to receive the $25,000 GE & Science Prize for Young ... Science , which is published by AAAS, the nonprofit society. ... Monday, 11 December, during an award ceremony. She will also ...
Other Biology News:Hopkins researchers discover how brain protein might control memory 2Hopkins researchers discover how brain protein might control memory 3GlycoFi and Dartmouth report full humanization of yeast glycosylation pathway in Science 2American scientist's research of life's first cells 2American scientist's research of life's first cells 3American scientist's research of life's first cells 4
... ReadyPrep overlay agarose, is a low ... sample setup to secure IPG strips in ... dye is incorporated to allow monitoring of ... 0.5% low melting point agarose in 1x ...
Criterion staining and blotting trays are plastic trays designed for staining one or two Criterion gels or performing western blot detection. The trays have a working capacity of up to 500 ml. Suppli...
... a wide range of next-generation features into ... new standard for flexible laboratory solutions. It ... including pipetting, dilution, dispensing, and integrations ... powerful and flexible as it is efficient ...
These Costar 96-well, flat-bottom polystyrene EIA plates are used for EIAs, ELISAs, and other protein binding assays. Supplied as box of 100 (20 packages; 5 plates per package)....
Biology Products: